Chemed Q1 Adj $5.20 Misses $5.48 Estimate, Sales $589.23M Miss $591.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemed (NYSE:CHE) reported Q1 adjusted earnings of $5.20 per share, missing the consensus estimate of $5.48, and sales of $589.23M, also below the estimate of $591.46M. Despite these misses, both earnings and sales showed an increase from the previous year.
April 24, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemed reported Q1 earnings and sales below analyst estimates but showed an increase from the previous year.
Missing the analyst consensus estimates for both earnings per share and sales typically leads to negative investor sentiment in the short term. However, the year-over-year growth in both metrics may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100